Hepatic Arterial Infusion Pump Chemotherapy in Patients With Unresectable Intrahepatic Cholangiocarcinoma—PUMP-2 Trial

Stijn Franssen(Erasmus MC Cancer Institute), Bas Groot Koerkamp, Wills F. Filipe(Erasmus MC Cancer Institute), Heinz‐Josef Klümpen(Amsterdam University Medical Centers), Florian E. Buisman(Erasmus MC Cancer Institute), Marjolein Y.V. Homs(Erasmus MC Cancer Institute), Jeroen Hagendoorn(Utrecht University), Nadia Haj Mohammad(Utrecht University), Merve Rousian(Erasmus MC Cancer Institute), B. Ten Haaft(Amsterdam University Medical Centers), Bianca Mostert(Erasmus MC Cancer Institute), Michael Doukas(Erasmus MC), Rutger‐Jan Swijnenburg(Amsterdam University Medical Centers)
Journal of Clinical Oncology
October 13, 2025
10.1200/jco-25-00923
Cited by 5

Related Papers

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2023|1k
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
|The Lancet Oncology|2016|914
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
|˜The œLancet. Gastroenterology & hepatology|2019|597
Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic Cholangiocarcinoma
|New England Journal of Medicine|2023|530
Surgery for cholangiocarcinoma
|Liver International|2019|338